In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen5,<scp>D</scp>Trp7,Dab8]urotensin II(4–11) (UFP‐803)

Valeria Camarda(University of Ferrara), Girolamo Calò(University of Padua), Martina Spagnol(University of Ferrara), David G. Lambert(Griffith University), Paolo Cavanni(GlaxoSmithKline (Italy)), Remo Guerrini(University of Ferrara), Wei Song(Wuhan University), Raffaella Vergura(University of Ferrara), Adelheid Roth(Aptuit (Italy)), D. Regoli(University of Ferrara), Severo Salvadori(University of Ferrara), Stephen A. Douglas(GlaxoSmithKline (United States)), Erika Marzola(University of Ferrara), David J. Rowbotham(Leicester Royal Infirmary), Jonathan P. Thompson(University of Leicester)

British Journal of Pharmacology

November 7, 2005

Cited by 32

|British Journal of Pharmacology|2021|488

|Nature|2012|474

|British Journal of Pharmacology|2000|432

|Science China Life Sciences|2022|404

|British Journal of Pharmacology|2023|390

<i>In vitro</i> and <i>in vivo</i> pharmacological characterization of the novel UT receptor ligand [Pen<sup>5</sup>,<scp>D</scp>Trp<sup>7</sup>,Dab<sup>8</sup>]urotensin II(4–11) (UFP‐803)